30 participants
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2026-05-22
- Completion:
- 2028-07-30
Conditions
- Multiple Myeloma
- AL Amyloidosis
Interventions
- DRUG
No Results Yet